BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6531431)

  • 1. Drug treatment of hyperlipidemia.
    Dujovne CA; Block JE
    Ration Drug Ther; 1984 Jun; 18(6):1-7. PubMed ID: 6531431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the lipid metabolic indices as affected by glycyrrhenate in experimental hyperlipidemia].
    Suetina IV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):47-50. PubMed ID: 7138977
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coenzyme A and dyslipidemia. Note III. Action of coenzyme A on changes in the blood lipid pattern after administration of dietary lipids].
    Consolo F; Di Tommaso G; Arrigo F; Trifirò A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1931-6. PubMed ID: 1231875
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
    Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
    Sterna R
    Ann Acad Med Stetin; 1997; 43():67-77. PubMed ID: 9471924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 7. FM-VP4 Forbes Medi-Tech.
    Burnett JR
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1120-5. PubMed ID: 14582458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemorheological aspects of hyperlipidemia].
    Elishkewitch K; Shapira I; Berliner S
    Harefuah; 2001 May; 140(5):435-6. PubMed ID: 11419070
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-experimental studies on decreasing blood lipids in geriatrics].
    Bracharz H; Laas H
    Med Monatsschr; 1966 Oct; 20(10):471-6. PubMed ID: 5978465
    [No Abstract]   [Full Text] [Related]  

  • 11. The MeOH extract of Pleurospermum kamtschaticum and its active component buddlejasaponin (IV) inhibits intrinsic and extrinsic hyperlipidemia and hypercholesterolemia in the rat.
    Jung HJ; Nam JH; Park HJ; Lee KT; Park KK; Kim WB; Choi J
    J Ethnopharmacol; 2007 Jun; 112(2):255-61. PubMed ID: 17433587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of hyperlipidemic states].
    Lipovetskiĭ BM; Triufanov VF; Konstantinov VO
    Klin Med (Mosk); 1980 Apr; 58(4):56-61. PubMed ID: 7382369
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of hyperlipidemia.
    Low Dog T; Riley D
    Altern Ther Health Med; 2003; 9(3):28-40; quiz 41. PubMed ID: 12776473
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacologic treatment of dyslipidemias: Analysis of initiation recommendations and drug selection].
    Davidoff P
    Rev Med Chil; 1991 Dec; 119(12):1423-32. PubMed ID: 9723101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiation and drug therapy of lipemias].
    Schettler G
    Dtsch Med J; 1968 Apr; 19(8):250-8. PubMed ID: 5728720
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hyperlipidemia in diabetes.
    Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y
    Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening and treatment of hyperlipidemias in Israel].
    Sehayek E; Eisenberg S
    Harefuah; 1995 May; 128(9):529-32, 600. PubMed ID: 7797148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in primary prevention among hyperlipidemic patients.
    McPherson R
    Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Piperazine sultosylate in the treatment of hyperlipidemias].
    Balaguer Vintro I; Duarte Mantilla G
    Rev Clin Esp; 1980 Jul 15-31; 158(1-2):37-40. PubMed ID: 6999559
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
    Panchenko VM; Ershov AA; Isaev VA
    Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.